| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JHEP.2011.01.051 |
| P698 | PubMed publication ID | 21354450 |
| P2093 | author name string | Janick Selves | |
| Christophe Bureau | |||
| Sophie Métivier | |||
| Bogdan Procopet | |||
| Jean Marie Péron | |||
| Jean Pierre Vinel | |||
| Marie Angèle Robic | |||
| P433 | issue | 5 | |
| P921 | main subject | portal hypertension | Q124604 |
| chronic liver disease | Q5113984 | ||
| P304 | page(s) | 1017-1024 | |
| P577 | publication date | 2011-02-25 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study | |
| P478 | volume | 55 |
| Q52642499 | A Prospective Blinded Study of Endoscopic Ultrasound Elastography in Liver Disease: Towards a Virtual Biopsy. |
| Q48132046 | Assessment of liver stiffness measurement: novel intraoperative blood loss predictor? |
| Q93355846 | Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up |
| Q41678369 | Checkmate to liver biopsy in chronic hepatitis C? |
| Q26822664 | Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives |
| Q26768262 | Clinical applications, limitations and future role of transient elastography in the management of liver disease |
| Q28468382 | Clinical role of non-invasive assessment of portal hypertension |
| Q38858344 | Critical comparison of elastography methods to assess chronic liver disease |
| Q59352739 | Determination of reliability criteria for liver stiffness evaluation by transient elastography |
| Q54234625 | Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies. |
| Q28546718 | Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis |
| Q52661700 | Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research. |
| Q34631908 | Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension |
| Q89736387 | Evaluation of endoscopic variceal band ligation sessions in obliteration of esophageal varices |
| Q40127532 | Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. |
| Q35785198 | Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis |
| Q26738597 | HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma |
| Q27026753 | Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region |
| Q30465982 | Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU |
| Q39210299 | Invasive and non-invasive assessment of portal hypertension. |
| Q30439743 | Invasive and non-invasive diagnosis of cirrhosis and portal hypertension |
| Q57818077 | Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations |
| Q64228859 | Liver stiffness and thrombin generation in compensated cirrhosis |
| Q35155090 | Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. |
| Q37511482 | Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis |
| Q30357059 | Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. |
| Q87664325 | Management of hepatocellular carcinoma |
| Q38088585 | Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension |
| Q36404873 | Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient. |
| Q26784251 | Molecular prognostic prediction in liver cirrhosis |
| Q30389327 | Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease |
| Q38073661 | Natural history of cirrhosis. |
| Q26744631 | Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy? |
| Q30427489 | Non-invasive assessment of liver fibrosis in chronic hepatitis B. |
| Q97518921 | Non-invasive tests for the prediction of primary hepatocellular carcinoma |
| Q30381236 | Noninvasive Measures of Liver Fibrosis and Severity of Liver Disease. |
| Q38635589 | Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)). |
| Q26853160 | Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond |
| Q90285914 | Noninvasive diagnosis in alcohol-related liver disease |
| Q38141711 | Noninvasive evaluation of NAFLD. |
| Q42202921 | Noninvasive evaluation of portal hypertension: emerging tools and techniques |
| Q48273203 | Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study. |
| Q26777483 | Personalized management of cirrhosis by non-invasive tests of liver fibrosis |
| Q88636602 | Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases |
| Q41928194 | Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after SVR in recurrent hepatitis C. |
| Q45378592 | Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C. |
| Q38985095 | Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study. |
| Q30434361 | Principles and clinical application of ultrasound elastography for diffuse liver disease |
| Q87903949 | Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease |
| Q90862928 | Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease |
| Q47595041 | Prognostic Value of Controlled Attenuation Parameter by Transient Elastography |
| Q40456677 | Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C. |
| Q52593455 | Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis. |
| Q35862847 | Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis. |
| Q52692830 | Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. |
| Q40072782 | Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals |
| Q38708562 | Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. |
| Q37716891 | Role of magnetic resonance elastography in compensated and decompensated liver disease |
| Q28072862 | Role of spleen elastography in patients with chronic liver diseases |
| Q30393911 | Serum Liver Fibrosis Markers for Predicting the Presence of Gastroesophageal Varices in Liver Cirrhosis: A Retrospective Cross-Sectional Study |
| Q30386872 | Simultaneous measurement of hepatic and splenic stiffness using MR elastography: preliminary experience. |
| Q30457472 | Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals |
| Q88638446 | Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases |
| Q37205472 | The Application of Liver Stiffness Measurement in Residents Without Overt Liver Diseases Through a Community-Based Screening Program |
| Q33810066 | The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations |
| Q30459018 | The impact of hepatic pressurization on liver shear wave speed estimates in constrained versus unconstrained conditions |
| Q53231247 | Toward new standards for noninvasive measuring of portal pressure? |
| Q83936544 | Transient elastography and prognosis of cirrhosis |
| Q41846141 | Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension? |
| Q36374829 | U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. |
| Q30434265 | Ultrasonic characterization of the nonlinear properties of canine livers by measuring shear wave speed and axial strain with increasing portal venous pressure |
| Q39166281 | Ultrasonography for Noninvasive Assessment of Portal Hypertension |
| Q26778038 | Ultrasound-based elastography for the diagnosis of portal hypertension in cirrhotics |
| Q38916843 | Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. |
| Q41147516 | Using Ultrasonic Transient Elastometry (FibroScan) to Predict Esophageal Varices in Patients with Viral Liver Cirrhosis |
| Q58760217 | Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial |
| Q41392739 | WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver |
Search more.